Merck KGaA Share Price Wiener Boerse

Equities

MRCK

DE0006599905

Pharmaceuticals

End-of-day quote Wiener Boerse 23:00:00 02/05/2024 BST 5-day change 1st Jan Change
152.2 EUR +1.03% Intraday chart for Merck KGaA -0.07% +6.47%

Financials

Sales 2024 * 21.26B 22.87B 1,824B Sales 2025 * 22.52B 24.24B 1,933B Capitalization 66.09B 71.11B 5,672B
Net income 2024 * 2.96B 3.18B 254B Net income 2025 * 3.49B 3.75B 299B EV / Sales 2024 * 3.43 x
Net Debt 2024 * 6.72B 7.23B 577B Net Debt 2025 * 4.9B 5.27B 421B EV / Sales 2025 * 3.15 x
P/E ratio 2024 *
22.3 x
P/E ratio 2025 *
18.9 x
Employees 62,908
Yield 2024 *
1.51%
Yield 2025 *
1.6%
Free-Float 29.71%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.03%
1 week-0.07%
Current month+2.11%
1 month-3.37%
3 months+3.29%
6 months+3.64%
Current year+6.47%
More quotes
1 week
149.00
Extreme 149
152.20
1 month
144.40
Extreme 144.4
154.50
Current year
141.30
Extreme 141.3
163.75
1 year
135.35
Extreme 135.35
170.55
3 years
134.75
Extreme 134.75
231.20
5 years
80.68
Extreme 80.68
231.20
10 years
74.82
Extreme 74.82
231.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 12/07/20
Director of Finance/CFO 56 31/07/14
Director of Finance/CFO 53 25/04/19
Members of the board TitleAgeSince
Director/Board Member 75 08/05/14
Chairman 67 25/04/19
Director/Board Member 61 30/04/12
More insiders
Date Price Change
03/05/24 152.2 +1.03%
02/05/24 150.6 +1.07%
30/04/24 149 -0.50%
29/04/24 149.8 -1.64%
26/04/24 152.2 +1.40%

End-of-day quote Wiener Boerse, May 02, 2024

More quotes
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
152 EUR
Average target price
182 EUR
Spread / Average Target
+19.74%
Consensus